Health

Ozempic and Wegovy drugmaker CEO defends high costs of drugs

Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the company’s weight-loss drugs Ozempic and Wegovy. NBC News’ Christine Romans reports on how Jørgensen claimed the high prices were due to complications of the U.S. healthcare system.

Sep 25, 2024 - 00:00
Ozempic and Wegovy drugmaker CEO defends high costs of drugs
Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the company’s weight-loss drugs Ozempic and Wegovy. NBC News’ Christine Romans reports on how Jørgensen claimed the high prices were due to complications of the U.S. healthcare system.
Read More

Tags:

Previous Article

Iron deficiency in adults may be more common than thought, leaving many 'running...

Next Article

RFK Jr. wants more scrutiny of chemicals, but Trump's EPA did the opposite

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

‘Voters just didn't care’: The abortion-rights movement grapples with Trump’s return

‘Voters just didn't care’: The abortion-rights movement...

Nov 18, 2024

What makes walking so great for your health and what else you need to do

What makes walking so great for your health and what el...

Nov 13, 2024

Covid infections on the rise, will fall boosters help?

Covid infections on the rise, will fall boosters help?

Aug 13, 2024